139 related articles for article (PubMed ID: 23213753)
1. [Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
Li Y; Xu Z; Zhang L; Quan C; Lin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):739-41, 746. PubMed ID: 23213753
[TBL] [Abstract][Full Text] [Related]
2. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.
Suchozebrska-Jesionek D; Szymański M; Kurzepa J; Gołabek W; Stryjecka-Zimmer M
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):628-32. PubMed ID: 19128667
[TBL] [Abstract][Full Text] [Related]
3. [Expression of transforming growth factor-beta 1 matrix metalloproteinase-1 and its inhibitor in human middle ear cholesteatoma].
Yang X; Li X; Ma M; Zhang L; Zhang Q; Wang J; Wang B
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):121-3. PubMed ID: 12768723
[TBL] [Abstract][Full Text] [Related]
4. Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas.
Shibosawa E; Tsutsumi K; Takakuwa T; Takahashi S
Am J Otol; 2000 Sep; 21(5):621-4. PubMed ID: 10993447
[TBL] [Abstract][Full Text] [Related]
5. [The expression and significance of DDR2 and MMP-13in human middle ear cholesteatoma].
Xu LF; Sun WZ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):938-941. PubMed ID: 29771058
[No Abstract] [Full Text] [Related]
6. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
Wang H; Xu Z; Tang A; Su J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
[TBL] [Abstract][Full Text] [Related]
7. [Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer].
Zhu W; Xie Y; Wang P
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):119-22. PubMed ID: 12761978
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
Zhang E; Gong S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
[TBL] [Abstract][Full Text] [Related]
9. [The expression of matrix metalloproteinase-9 and tumor necrosis factor-alpha in cholesteatoma].
Li N; Qin Z; Dong M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):424-6. PubMed ID: 15499988
[TBL] [Abstract][Full Text] [Related]
10. [The expression and significance of human beta-defensin 2 in middle ear cholesteatoma epithelium].
Ren X; Cui P; Chen W; Xu M
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(7):313-4. PubMed ID: 16001900
[TBL] [Abstract][Full Text] [Related]
11. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
12. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
[TBL] [Abstract][Full Text] [Related]
13. [Expression of matrix metalloproteinase-2,9 in cholesteatoma from different positions].
Wang J; Yu LS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):44-8. PubMed ID: 19484988
[TBL] [Abstract][Full Text] [Related]
14. Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study.
Lei Y; An J; Ren Q; Wang M; Gao M
Medicine (Baltimore); 2023 Oct; 102(43):e35538. PubMed ID: 37904429
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in cholesteatoma.
Olszewska E; Matulka M; Mroczko B; Pryczynicz A; Kemona A; Szmitkowski M; Mierzwinski J; Pietrewicz T
Histol Histopathol; 2016 Mar; 31(3):307-15. PubMed ID: 26490574
[TBL] [Abstract][Full Text] [Related]
16. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle inhibitory protein p27 in human middle ear cholesteatoma.
Kuczkowski J; Bakowska A; Pawelczyk T; Narozny W; Mikaszewski B
ORL J Otorhinolaryngol Relat Spec; 2006; 68(5):296-301. PubMed ID: 16825801
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
[TBL] [Abstract][Full Text] [Related]
19. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
Li Z; Li X; Liu G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
[TBL] [Abstract][Full Text] [Related]
20. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
Juhász A; Sziklai I; Rákosy Z; Ecsedi S; Adány R; Balázs M
Otol Neurotol; 2009 Jun; 30(4):559-65. PubMed ID: 19395987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
